Holocene Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$18.6M Buy
2021
Q4
Sell
2021
Q3
$14.1M Sell
2021
Q2
$20.8M Buy